News

News

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

Monday 19 March 2012

Please click here to view this document.

Back to News Listing

News

Scientific and legal challenges to the functional capacity evaluation in chronic fatigue syndrome

Scientific and legal challenges to the functional capacity evaluation in chronic fatigue syndrome

Functional capacity evaluation of  CFS. Is this  the best way to determine …

Read more

Medical Expert Seminar: M.E/CFS/Fibromyalgia - Sat 21st September

Medical Expert Seminar: M.E/CFS/Fibromyalgia - Sat 21st September

International and national medical expert seminar Professor Dr. Michael Maes and Dr. Nicole …

Read more

Chronic Fatigue Syndrome: Inherited common virus, Human Herpesvirus 6 (HHV-6), Can Cause Cognitive Dysfunction and Fatigue

Chronic Fatigue Syndrome: Inherited common virus, Human Herpesvirus 6 (HHV-6), Can Cause Cognitive Dysfunction and Fatigue

The study reports that antiviral drugs improve the severe neurological symptoms, including chronic …

Read more
Find more news here

Did you know?

As many as 180,000 Australians are directly affected by ME/CFS

Research


Research into ME/CFS is occuring across the globe. Follow the links below for research resources.

 


Support Organisations by State

ME/CFS Australia directs enquiries from members of the community about frontline support for people with ME/CFS to independently run state organisations.



Western Australia New Zealand Tasmania Queensland Northern Territory South Australia Victoria New South Wales Act